Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004049579 | SCV002617516 | uncertain significance | not specified | 2024-06-29 | criteria provided, single submitter | clinical testing | The p.L1219P variant (also known as c.3656T>C), located in coding exon 6 of the MLH3 gene, results from a T to C substitution at nucleotide position 3656. The leucine at codon 1219 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005008539 | SCV005635757 | uncertain significance | Endometrial carcinoma; Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer | 2024-06-08 | criteria provided, single submitter | clinical testing |